Researchers found that certain immune cells, genes, and the drug metformin may help keep HIV dormant after treatment stops, ...

HealthDay News — Intralesional nivolumab seems effective for reducing the size of precancerous oral lesions, according to a study presented at the annual meeting of the American Association for Cancer ...

Intralesional nivolumab seems effective for reducing the size of precancerous oral lesions, according to a study presented at ...

Mozart Therapeutics, the leading developer of CD8 Treg network modulators for the treatment of autoimmune disease, today ...

Non-cardiotoxic anthracycline demonstrates activity where traditional chemotherapies have historically failed, supporting potential expansion of ...

Scientific Advisory Board (SAB) includes experts in the development and approved T-cell engager therapies, supporting CAPTN-3’s advancement ...

Researchers have engineered a synthetic Notch receptor system to directly label and profile cells interacting with developing T cells in the thymus. The study identified a broad network of immune and ...

A new UCLA Health Jonsson Comprehensive Cancer Center study suggests that the way immune cells are organized inside melanoma ...

While modern life includes many conveniences, humans are still incessantly exposed to a variety of metabolic stresses we have ...

Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, presented new data at the American ...

While modern life includes many conveniences, humans are still incessantly exposed to a variety of metabolic stresses we have ...

Fred Hutch Cancer Center molecular biologist Dr. Kevin Barry just received a $270,000, two-year grant from the American ...